Detection of Menopause Onset Can Improve Quality of Life and Long-Term Health
- A Simple, Non-Invasive Test 'Menocheck(R)' is Now Available at Rite Aid
MEDIA, Pa., June 14 /PRNewswire-FirstCall/ -- Synova Healthcare Group,
Inc. (SNVH) announced today that it has received an initial opening order for
Menocheck(R) from the Rite Aid Corporation. Rite Aid is one of the nation's
leading drugstore chains and currently operates approximately 3,400 stores in
28 states and the District of Columbia. Consumers shopping for Menocheck(R)
at Rite Aid stores will find the product arriving on store shelves throughout
the month of June.
Menocheck(R) is a simple at-home urine test that allows women to
accurately check for the onset of menopause in the privacy of their own home.
It detects elevated levels of a hormone known as follicle stimulating hormone
(FSH), which becomes elevated with the onset of menopause. Each Menocheck(R)
-- Menopause Indicator Test package comes with two individually wrapped test
devices, which are used five to seven days apart in order to confirm that FSH
levels have remained elevated over the testing period. Two positive
Menocheck(R) test results are then suggestive of the onset of menopause, and
women are encouraged to take these findings to their health care providers in
order to discuss potential treatment plans as they enter this phase of life.
Early detection of the onset of menopause is an important first step to
improved quality of life and long term health for the millions of American
women who enter menopause annually. In the medical community, it is a well
known fact that menopausal women are at a greater risk for diseases such as
osteoporosis and cardiovascular disease. Menocheck(R) is easy-to-use and
offers women the convenience of a one-step at-home test, and is a non-invasive
alternative to clinical blood testing for initial menopause screenings.
Introduced in late 2003, Menocheck(R) was the first over the counter
menopause indicator test to have been made commercially available through
retail pharmacies. "We are very pleased to now be adding Rite Aid stores to
our impressive list of fine retailers that offer Menocheck(R) for sale",
stated company President, Mr. David Harrison. Synova's growing retail
distribution network for Menocheck(R) already includes leading retailers like
Walgreens, Albertsons, Eckerd, Duane Reed, Kroger, Longs Drugs and Happy
Non-invasive and similar to an at-home pregnancy test in design,
Menocheck(R) works by measuring the level of follicle stimulating hormone
(FSH) in the urine. As women enter menopause, FSH levels gradually rise and
stay permanently higher once menopause has set in. Menocheck(R) is FDA
Each Menocheck(R) package includes two test devices and simple-to-follow
instructions, and when used as directed has been shown to be *99% accurate.
Menocheck(R) typically retails for $19.99, and is now widely available at fine
retailers nationwide. For more information about menopause and Menocheck(R)
consumers can visit http://www.menocheck.com .
* 99% accuracy agreement in studies conducted with consumers/lay persons
About Synova Healthcare, Inc.:
Synova Healthcare Inc., a wholly owned subsidiary of Synova Healthcare
Group, Inc. (SNVH), distributes rapid, non-invasive medical diagnostics at
retail for over-the-counter (OTC) use, and direct to health care providers for
point of care (POC) use in the clinical setting. The company's products
improve human health and quality of life by providing early and accurate
awareness of the onset of certain medical conditions.
This Press Release may contain certain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995. The
Company has tried, whenever possible, to identify these forward-looking
statements using words such as "anticipates," "believes," "estimates,"
"expects," "plans," "intends," "potential" and similar expressions. These
statements reflect the Company's current beliefs and are based upon
information currently available to it. Accordingly, such forward-looking
statements involve known and unknown risks, uncertainties and other factors
which could cause the Company's actual results, performance or achievements to
differ materially from those expressed in or implied by such statements. The
Company undertakes no obligation to update or advise in the event of any
change, addition or alteration to the information catered in this Press
Release including such forward-looking statements. This press release does not
constitute an offer to sell or the solicitation of an offer to buy; nor will
there be any sale of securities of Synova Healthcare Group, Inc. in any state
where such offer, solicitation or sale would be unlawful before registration
or qualification under the securities laws of those states.
SOURCE Synova Healthcare Group, Inc.
Web Site: http://www.synovahealthcare.com
No part of this article may be reproduced in full or in part
without express written permission of the publisher.
All of the information
contained in the menopause A to Z web site and any associated electronic
publications, to include electronic books ("e-Books"), emails,
newsletters and links are provided for educational and entertainment
purposes ONLY. Neither the FDA, nor any other medical or government
authority has evaluated the information. Nor does the information
presented always represent the consensus of most physicians. The
information is not intended to diagnose, treat, cure, or prevent any
disease, nor should it be used as a therapeutic modality or as a
substitute for your own physician's advice.
Click Here to
Read Full Medical Disclaimer
| Terms Of Service |
Privacy Notice |